Nasdaq IPOs

Global SPAC Partners, a blank check company formed by ASMA Capital targeting businesses in MENA and South Asia, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. The Claymont, DE-based company plans to raise $200 million by offering 20 milli

Natural Order Acquisition, a blank check company focusing on technologies and products related to sustainable plant-based food and beverages, filed on Tuesday with the SEC to raise up to $250 million in an initial public offering. The Weston, MA-based company plans to raise

Investindustrial Acquisition, a blank check company formed by Investindustrial, filed on Tuesday with the SEC to raise up to $350 million in an initial public offering. The London, UK-based company plans to raise $350 million by offering 35 million units at $10. Each unit consist

McAfee, a leading provider of antivirus and endpoint security software, announced terms for its IPO on Tuesday. The San Jose, CA-based company plans to raise $759 million by offering 37 million shares (16% insider) at a price range of $19 to $22. At the midpoint of the proposed r

Seaport Global Acquisition, a blank check company formed by Seaport Global Asset Management (SGAM) targeting distressed businesses, filed on Tuesday with the SEC to raise up to $125 million in an initial public offering. The New York-based company plans to raise $125 million

Array Technologies, which manufactures solar panel mounting systems that track the sun, raised the proposed deal size for its upcoming IPO on Tuesday. The Albuquerque, NM-based company now plans to raise $900 million by offering 45 million shares (84% insider) at a price range of

Lixte Biotechnology Holdings, a Phase 2 biotech using biomarker technology to develop protein inhibitors for cancer, announced terms for its IPO on Tuesday. The East Setauket, NY-based company plans to raise $9 million by offering 1.5 million shares at a price range of $5.75 to $

The 3Q20 was a record-breaking quarter for IPO activity, with 81 IPOs raising $28.5 billion. Soaring peer multiples and IPO enthusiasm caused activity to increase significantly from the 3Q19, when 39 IPOs raised $10.8 billion. Healthcare was the most active sector, as larger heal

Kingswood Acquisition, a blank check company formed by Kingswood targeting the financial services industry, filed on Tuesday with the SEC to raise up to $150 million in an initial public offering. The New York-based company plans to raise $150 million by offering 15 million

Decarbonization Plus Acquistion, a third blank check company formed by Riverstone targeting businesses advancing global decarbonization, lowered the proposed deal size for its upcoming IPO on Tuesday. The Menlo Park, CA-based company now plans to raise $200 million by offering 20

Turmeric Acquisition, a blank check company formed by MPM Capital targeting the biotech industry, lowered the proposed deal size for its upcoming IPO on Tuesday. The Cambridge, MA-based company now plans to raise $85 million by offering 8.5 million units at $10. The company had p

Five biotechs, two medical device makers, a solar panel mounting manufacturer, and a Chinese retailer are scheduled to raise $2.0 billion in the week ahead. Several companies could join the IPO calendar early in the week, including leading cybersecurity brand McAfee (MCFE) and V

Seven IPOs and 10 SPACs went public this past week. The IPO pipeline remained active, with 11 IPOs and 22 SPACs submitting initial filings. Phase 2 biotech Kronos Bio (KRON) priced above the range to raise $250 million at a $1.1 billion market cap. The biotech is developing ther

Spartan Acquisition II, the second blank check company formed by Apollo Global Management targeting the North American energy industry, filed on Friday with the SEC to raise up to $400 million in an initial public offering. The New York-based company plans to raise $400 mill

Yellowstone Acquisition, a blank check company formed by Boston Omaha Corp. targeting the financial and real estate sectors, lowered the proposed deal size for its upcoming IPO on Friday. The Omaha, NE-based company now plans to raise $150 million by offering 15 million units at

Lux Health Tech Acquisition, a blank check company formed by Lux Capital targeting a healthtech business, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million unit

SQZ Biotechnologies, a Phase 1 biotech developing cell therapies for solid tumors and other indications, filed on Friday with the SEC to raise up to $75 million in an initial public offering. The company is developing cell therapies for cancer, infectious diseases, and other

Tarsus Pharmaceuticals, a Phase 3 biotech developing therapies for ophthalmic conditions, announced terms for its IPO on Friday. The Irvine, CA-based company plans to raise $80 million by offering 5 million shares at a price range of $15 to $17. At the midpoint of the proposed ra

Aligos Therapeutics, a Phase 1 biotech developing oligonucleotide therapies for viral and liver diseases, announced terms for its IPO on Friday. The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At

Eargo, which manufactures differentiated hearing aid systems, announced terms for its IPO on Friday. The San Jose, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Eargo would comman